KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced V114, the company’s investigational 15-valent pneumococcal conjugate vaccine, ...
Following previous research showing frequency and direction of conjugate lateral eye-movements (CLEMs) to be a valid indicator of hemispheric asymmetry (Schwartz, Davidson, & Maer, 1975), the purpose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback